Endurant Capital Management’s AbbVie ABBV Stock Holding History

Endurant Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-180,429	Closed	-$19.5M	–	68
2021 Q3	$19.5M	Buy	180,429 +94,915	+111%	+$10.8M	4.43%	4
2021 Q2	$9.63M	Sell	85,514 -2,468	-3%	-$278K	2.65%	10
2021 Q1	$9.52M	Buy	87,982 +3,438	+4%	+$368K	2.48%	15
2020 Q4	$9.06M	Sell	84,544 -114,377	-57%	-$11M	3.27%	5
2020 Q3	$17.4M	Buy	198,921 +136,306	+218%	+$12.8M	5.15%	5
2020 Q2	$6.15M	Buy	+62,615	New	+$5.51M	0.34%	17
2020 Q1	–	Sell	-98,596	Closed	-$8.73M	–	52
2019 Q4	$8.73M	Sell	98,596 -63,411	-39%	-$5.26M	2.75%	13
2019 Q3	$12.3M	Buy	162,007 +72,999	+82%	+$5M	4.4%	10
2019 Q2	$6.47M	Buy	89,008 +67,334	+311%	+$5.29M	2.55%	18
2019 Q1	$1.75M	Buy	+21,674	New	+$1.77M	0.69%	44
2016 Q2	–	Sell	-6,700	Closed	-$383K	–	89
2016 Q1	$383K	Sell	6,700 -80,600	-92%	-$4.49M	0.12%	77
2015 Q4	$5.17M	Buy	87,300 +70,900	+432%	+$4.08M	1.73%	18
2015 Q3	$892K	Buy	+16,400	New	+$1.07M	0.3%	61
2015 Q1	–	Sell	-33,301	Closed	-$2.18M	–	97
2014 Q4	$2.18M	Buy	+33,301	New	+$2.1M	0.85%	41

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Endurant Capital Management's ABBV Position: Q4 2021 in Review

Endurant Capital Management sold out of AbbVie (ABBV) in Q4 2021, closing a stake of 180,429 shares — an estimated $19.5M sold.

Endurant Capital Management first reported a position in ABBV in Q4 2014 and held it in 14 quarters. The position peaked at $19.5M in Q3 2021. 2,982 funds tracked by Wall St. Rank hold ABBV as of Q4 2021.

Endurant Capital Management reported no remaining AbbVie position as of Q4 2021 after selling out during the quarter.
Endurant Capital Management sold 180,429 AbbVie shares in Q4 2021, an estimated $19.5M.
Endurant Capital Management first reported a position in AbbVie in Q4 2014 and held it in 14 quarters.
Endurant Capital Management's AbbVie position peaked at $19.5M in Q3 2021.
2,982 funds tracked by Wall St. Rank held AbbVie as of Q4 2021.

Based on Endurant Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.